Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-013-2827-0.

Title:
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study | Breast Cancer Research and Treatment
Description:
Choice of therapy for breast cancer relies on human epidermal growth factor receptor-2 (HER2) and estrogen receptor α (ER) status. Before randomization in the phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation (ALTTO) trial for HER2-positive disease, HER2 and ER were centrally reviewed by Mayo Clinic (Rochester, MN, and Scottsdale, AZ) for North America and by the European Institute of Oncology (IEO; Milan, Italy) for the rest of world (except China). Discordance rates (local vs. central review) differed between Mayo and IEO. Among locally HER2-positive cases, 5.8 % (Mayo) and 14.5 % (IEO) were centrally HER2 negative. Among locally ER-positive cases, 16.2 % (Mayo) and 4.2 % (IEO) were centrally ER-negative. Among locally ER-negative cases, 3.4 % (Mayo) and 21.4 % (IEO) were centrally ER-positive. We, therefore, performed a ring study to identify features contributing to these differing discordance rates. Mayo and IEO exchanged slides for 25 HER2 and 35 ER locally/centrally discordant cases. Both laboratories performed IHC and FISH for HER2 using the HercepTest® and PathVysion HER2 DNA probe kit/HER2/centromere 17 probe mixture. IHC for ER was tested centrally using the monoclonal ER 1D5 antibody (Mayo) or the DAKO cocktail of ER 1D5 and 2.123 antibodies (IEO). Mayo and IEO confirmed the central HER2-negative result in 100 % of 25 cases. Mayo and IEO confirmed the central ER result in 29 (85 %) of 34 evaluable cases. The five Mayo-negative/IEO-positive cases were ER-positive when retested at Mayo using the DAKO ER cocktail. In this ring study, ALTTO ineligibility did not change when HER2 testing was performed by either IEO or Mayo central laboratories. However, a dual antibody ER assay had fewer false-negative test results than an assay with a single antibody, and there was more discordance between the two ER reagents than has been previously reported. Using even slightly different assay methods yielded different results, even between experienced central laboratories.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

cancer, article, breast, mayo, central, ieo, research, google, scholar, clinical, pubmed, study, receptor, cases, testing, usa, review, altto, trial, ring, centrally, access, cas, american, privacy, cookies, content, laboratory, mccullough, perez, therapy, estrogen, adjuvant, dako, data, information, publish, search, early, ncctg, richard, gelber, dueck, human, epidermal, growth, factor, clinic, discordance, performed,

Topics {✒️}

asco/cap her2-positivity criteria her2-low versus her2 month download article/chapter central her2-negative result dana-farber cancer institute locally her2-positive cases mayo-negative/ieo-positive cases estrogen receptor α locally er-positive cases locally er-negative cases clinical trials early breast cancer central review breast cancer relies central er result clinical oncology/college experienced central laboratories technology research foundation full article pdf systematic review laboratory medicine privacy choices/manage cookies mayo central laboratories her2 testing her2-positive disease related subjects centrally her2 negative immunohistochemical testing breast cancer piccart-gebhart centrally er-positive centrally er-negative patrizia dell’orto local check access instant access christian jackisch dako er cocktail central laboratories differing discordance rates altto study team stefania andrighetto trastuzumab treatment optimisation identify features contributing situ hybridization assessment nih/nci grant ring study reported tamoxifen adjuvant therapy classifying her2 status conditions privacy policy

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study
         description:Choice of therapy for breast cancer relies on human epidermal growth factor receptor-2 (HER2) and estrogen receptor α (ER) status. Before randomization in the phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation (ALTTO) trial for HER2-positive disease, HER2 and ER were centrally reviewed by Mayo Clinic (Rochester, MN, and Scottsdale, AZ) for North America and by the European Institute of Oncology (IEO; Milan, Italy) for the rest of world (except China). Discordance rates (local vs. central review) differed between Mayo and IEO. Among locally HER2-positive cases, 5.8 % (Mayo) and 14.5 % (IEO) were centrally HER2 negative. Among locally ER-positive cases, 16.2 % (Mayo) and 4.2 % (IEO) were centrally ER-negative. Among locally ER-negative cases, 3.4 % (Mayo) and 21.4 % (IEO) were centrally ER-positive. We, therefore, performed a ring study to identify features contributing to these differing discordance rates. Mayo and IEO exchanged slides for 25 HER2 and 35 ER locally/centrally discordant cases. Both laboratories performed IHC and FISH for HER2 using the HercepTest® and PathVysion HER2 DNA probe kit/HER2/centromere 17 probe mixture. IHC for ER was tested centrally using the monoclonal ER 1D5 antibody (Mayo) or the DAKO cocktail of ER 1D5 and 2.123 antibodies (IEO). Mayo and IEO confirmed the central HER2-negative result in 100 % of 25 cases. Mayo and IEO confirmed the central ER result in 29 (85 %) of 34 evaluable cases. The five Mayo-negative/IEO-positive cases were ER-positive when retested at Mayo using the DAKO ER cocktail. In this ring study, ALTTO ineligibility did not change when HER2 testing was performed by either IEO or Mayo central laboratories. However, a dual antibody ER assay had fewer false-negative test results than an assay with a single antibody, and there was more discordance between the two ER reagents than has been previously reported. Using even slightly different assay methods yielded different results, even between experienced central laboratories.
         datePublished:2014-01-07T00:00:00Z
         dateModified:2014-01-07T00:00:00Z
         pageStart:485
         pageEnd:492
         sameAs:https://doi.org/10.1007/s10549-013-2827-0
         keywords:
            Breast cancer
            Estrogen receptor testing
            HER2 testing
            Central laboratory review
            Local versus central laboratory concordance
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2827-0/MediaObjects/10549_2013_2827_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2827-0/MediaObjects/10549_2013_2827_Fig2_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:143
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ann E. McCullough
               affiliation:
                     name:Mayo Clinic Arizona
                     address:
                        name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Patrizia Dell’Orto
               affiliation:
                     name:University of Milan
                     address:
                        name:European Institute of Oncology, University of Milan, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Monica M. Reinholz
               affiliation:
                     name:Ventana Medical Systems
                     address:
                        name:Ventana Medical Systems, Tucson, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Richard D. Gelber
               affiliation:
                     name:Mailstop CLSB 11007
                     address:
                        name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Mailstop CLSB 11007, Boston, USA
                        type:PostalAddress
                     type:Organization
                     name:Frontier Science and Technology Research Foundation
                     address:
                        name:Frontier Science and Technology Research Foundation, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Amylou C. Dueck
               affiliation:
                     name:Mayo Clinic Arizona
                     address:
                        name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Leila Russo
               affiliation:
                     name:University of Milan
                     address:
                        name:European Institute of Oncology, University of Milan, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert B. Jenkins
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stefania Andrighetto
               affiliation:
                     name:University of Milan
                     address:
                        name:European Institute of Oncology, University of Milan, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Beiyun Chen
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christian Jackisch
               affiliation:
                     name:Klinikum Offenbach
                     address:
                        name:Klinikum Offenbach, Offenbach, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael Untch
               affiliation:
                     name:HELIOS Klinikum Berlin Buch
                     address:
                        name:HELIOS Klinikum Berlin Buch, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Edith A. Perez
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martine J. Piccart-Gebhart
               affiliation:
                     name:Université Libre de Bruxelles
                     address:
                        name:Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giuseppe Viale
               affiliation:
                     name:University of Milan
                     address:
                        name:European Institute of Oncology, University of Milan, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study
      description:Choice of therapy for breast cancer relies on human epidermal growth factor receptor-2 (HER2) and estrogen receptor α (ER) status. Before randomization in the phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation (ALTTO) trial for HER2-positive disease, HER2 and ER were centrally reviewed by Mayo Clinic (Rochester, MN, and Scottsdale, AZ) for North America and by the European Institute of Oncology (IEO; Milan, Italy) for the rest of world (except China). Discordance rates (local vs. central review) differed between Mayo and IEO. Among locally HER2-positive cases, 5.8 % (Mayo) and 14.5 % (IEO) were centrally HER2 negative. Among locally ER-positive cases, 16.2 % (Mayo) and 4.2 % (IEO) were centrally ER-negative. Among locally ER-negative cases, 3.4 % (Mayo) and 21.4 % (IEO) were centrally ER-positive. We, therefore, performed a ring study to identify features contributing to these differing discordance rates. Mayo and IEO exchanged slides for 25 HER2 and 35 ER locally/centrally discordant cases. Both laboratories performed IHC and FISH for HER2 using the HercepTest® and PathVysion HER2 DNA probe kit/HER2/centromere 17 probe mixture. IHC for ER was tested centrally using the monoclonal ER 1D5 antibody (Mayo) or the DAKO cocktail of ER 1D5 and 2.123 antibodies (IEO). Mayo and IEO confirmed the central HER2-negative result in 100 % of 25 cases. Mayo and IEO confirmed the central ER result in 29 (85 %) of 34 evaluable cases. The five Mayo-negative/IEO-positive cases were ER-positive when retested at Mayo using the DAKO ER cocktail. In this ring study, ALTTO ineligibility did not change when HER2 testing was performed by either IEO or Mayo central laboratories. However, a dual antibody ER assay had fewer false-negative test results than an assay with a single antibody, and there was more discordance between the two ER reagents than has been previously reported. Using even slightly different assay methods yielded different results, even between experienced central laboratories.
      datePublished:2014-01-07T00:00:00Z
      dateModified:2014-01-07T00:00:00Z
      pageStart:485
      pageEnd:492
      sameAs:https://doi.org/10.1007/s10549-013-2827-0
      keywords:
         Breast cancer
         Estrogen receptor testing
         HER2 testing
         Central laboratory review
         Local versus central laboratory concordance
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2827-0/MediaObjects/10549_2013_2827_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2827-0/MediaObjects/10549_2013_2827_Fig2_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:143
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ann E. McCullough
            affiliation:
                  name:Mayo Clinic Arizona
                  address:
                     name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Patrizia Dell’Orto
            affiliation:
                  name:University of Milan
                  address:
                     name:European Institute of Oncology, University of Milan, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Monica M. Reinholz
            affiliation:
                  name:Ventana Medical Systems
                  address:
                     name:Ventana Medical Systems, Tucson, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Richard D. Gelber
            affiliation:
                  name:Mailstop CLSB 11007
                  address:
                     name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Mailstop CLSB 11007, Boston, USA
                     type:PostalAddress
                  type:Organization
                  name:Frontier Science and Technology Research Foundation
                  address:
                     name:Frontier Science and Technology Research Foundation, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Amylou C. Dueck
            affiliation:
                  name:Mayo Clinic Arizona
                  address:
                     name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Leila Russo
            affiliation:
                  name:University of Milan
                  address:
                     name:European Institute of Oncology, University of Milan, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert B. Jenkins
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stefania Andrighetto
            affiliation:
                  name:University of Milan
                  address:
                     name:European Institute of Oncology, University of Milan, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Beiyun Chen
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christian Jackisch
            affiliation:
                  name:Klinikum Offenbach
                  address:
                     name:Klinikum Offenbach, Offenbach, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael Untch
            affiliation:
                  name:HELIOS Klinikum Berlin Buch
                  address:
                     name:HELIOS Klinikum Berlin Buch, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Edith A. Perez
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martine J. Piccart-Gebhart
            affiliation:
                  name:Université Libre de Bruxelles
                  address:
                     name:Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giuseppe Viale
            affiliation:
                  name:University of Milan
                  address:
                     name:European Institute of Oncology, University of Milan, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:143
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Mayo Clinic Arizona
      address:
         name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
         type:PostalAddress
      name:University of Milan
      address:
         name:European Institute of Oncology, University of Milan, Milan, Italy
         type:PostalAddress
      name:Ventana Medical Systems
      address:
         name:Ventana Medical Systems, Tucson, USA
         type:PostalAddress
      name:Mailstop CLSB 11007
      address:
         name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Mailstop CLSB 11007, Boston, USA
         type:PostalAddress
      name:Frontier Science and Technology Research Foundation
      address:
         name:Frontier Science and Technology Research Foundation, Boston, USA
         type:PostalAddress
      name:Mayo Clinic Arizona
      address:
         name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
         type:PostalAddress
      name:University of Milan
      address:
         name:European Institute of Oncology, University of Milan, Milan, Italy
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:University of Milan
      address:
         name:European Institute of Oncology, University of Milan, Milan, Italy
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Klinikum Offenbach
      address:
         name:Klinikum Offenbach, Offenbach, Germany
         type:PostalAddress
      name:HELIOS Klinikum Berlin Buch
      address:
         name:HELIOS Klinikum Berlin Buch, Berlin, Germany
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Université Libre de Bruxelles
      address:
         name:Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
         type:PostalAddress
      name:University of Milan
      address:
         name:European Institute of Oncology, University of Milan, Milan, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ann E. McCullough
      affiliation:
            name:Mayo Clinic Arizona
            address:
               name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Patrizia Dell’Orto
      affiliation:
            name:University of Milan
            address:
               name:European Institute of Oncology, University of Milan, Milan, Italy
               type:PostalAddress
            type:Organization
      name:Monica M. Reinholz
      affiliation:
            name:Ventana Medical Systems
            address:
               name:Ventana Medical Systems, Tucson, USA
               type:PostalAddress
            type:Organization
      name:Richard D. Gelber
      affiliation:
            name:Mailstop CLSB 11007
            address:
               name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Mailstop CLSB 11007, Boston, USA
               type:PostalAddress
            type:Organization
            name:Frontier Science and Technology Research Foundation
            address:
               name:Frontier Science and Technology Research Foundation, Boston, USA
               type:PostalAddress
            type:Organization
      name:Amylou C. Dueck
      affiliation:
            name:Mayo Clinic Arizona
            address:
               name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
               type:PostalAddress
            type:Organization
      name:Leila Russo
      affiliation:
            name:University of Milan
            address:
               name:European Institute of Oncology, University of Milan, Milan, Italy
               type:PostalAddress
            type:Organization
      name:Robert B. Jenkins
      affiliation:
            name:Mayo Clinic
            address:
               name:Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Stefania Andrighetto
      affiliation:
            name:University of Milan
            address:
               name:European Institute of Oncology, University of Milan, Milan, Italy
               type:PostalAddress
            type:Organization
      name:Beiyun Chen
      affiliation:
            name:Mayo Clinic
            address:
               name:Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Christian Jackisch
      affiliation:
            name:Klinikum Offenbach
            address:
               name:Klinikum Offenbach, Offenbach, Germany
               type:PostalAddress
            type:Organization
      name:Michael Untch
      affiliation:
            name:HELIOS Klinikum Berlin Buch
            address:
               name:HELIOS Klinikum Berlin Buch, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Edith A. Perez
      affiliation:
            name:Mayo Clinic
            address:
               name:Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Martine J. Piccart-Gebhart
      affiliation:
            name:Université Libre de Bruxelles
            address:
               name:Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Giuseppe Viale
      affiliation:
            name:University of Milan
            address:
               name:European Institute of Oncology, University of Milan, Milan, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
      name:European Institute of Oncology, University of Milan, Milan, Italy
      name:Ventana Medical Systems, Tucson, USA
      name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Mailstop CLSB 11007, Boston, USA
      name:Frontier Science and Technology Research Foundation, Boston, USA
      name:Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, USA
      name:European Institute of Oncology, University of Milan, Milan, Italy
      name:Mayo Clinic, Rochester, USA
      name:European Institute of Oncology, University of Milan, Milan, Italy
      name:Mayo Clinic, Rochester, USA
      name:Klinikum Offenbach, Offenbach, Germany
      name:HELIOS Klinikum Berlin Buch, Berlin, Germany
      name:Mayo Clinic, Jacksonville, USA
      name:Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
      name:European Institute of Oncology, University of Milan, Milan, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(76)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.77s.